International Journal of Infectious Diseases

Papers
(The H4-Index of International Journal of Infectious Diseases is 49. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Clostridioides difficile infection and recurrence in cancer patients (CIRCA): A multicentre, international study773
Corrigendum to ‘Current microbiological testing approaches and documented infections at febrile neutropenia onset in patients with hematologic malignancies’ [Int J Infect Dis. 2024 Oct:147:107183]566
Toward a molecular microbial blood test for tuberculosis infection338
Household clustering supports a novel chemoprophylaxis trial design for a mosquito-borne viral disease266
Concerns about statistical analyses in the study on polymyxin B treatment of carbapenem-resistant gram-negative bacilli infections214
Effects of extended anaerobic antibiotic coverage on anaerobic bloodstream infection: A multisite retrospective study140
Genetic mutations associated with rifampicin and isoniazid resistance in tuberculosis patients in Bhubaneswar, India129
Understanding the transmission dynamics of a large-scale measles outbreak in Southern Vietnam119
Impact of anti-fibrotic medications on post-COVID-19 pulmonary fibrosis: A systematic review and meta-analysis118
Effect of mandating vaccination on COVID-19 cases in colleges and universities92
The changing funding landscape for infectious disease research and control: implications for resource-limited countries84
Cytomegalovirus infection prevention counselling during pregnancy in France: a national population-based study80
Continental Strategic Framework to Strengthen Cross-Border Surveillance, Coordination and Information Sharing in Africa79
Programmatic management of tuberculosis preventive therapy: Past, present, future74
Tuberculosis vaccines update: Is an RNA-based vaccine feasible for tuberculosis?73
Bloodstream infections in hospitalized patients before and during the COVID-19 surge in a community hospital in the South Bronx71
Safety, immunogenicity, and lot-to-lot consistency of a multidose Sabin strain-based inactivated polio vaccine: a phase III, randomized, blinded, positive-control clinical trial in infants aged 2 mont70
Changing epidemiologic patterns of typhus group rickettsiosis and scrub typhus in China, 1950-202268
COVID-19 Pandemic Causes Increased Clinic Visits with Diagnosis of Tegumentary Leishmaniasis in Brazil in 202066
Recurrent and persistent fever after SARS-CoV-2 infection in patients with follicular lymphoma: A case series66
Potential determinants of the decline in mpox cases in Belgium: A behavioral, epidemiological and seroprevalence study64
Bridging the last mile: The critical role of local civil society in advancing equity and inclusion for neglected tropical diseases64
Genotypic diversity and antimicrobial resistance determinants in Salmonella Typhi isolated from children living in informal settlements in Nairobi, Kenya63
Safety and immunogenicity of a homologous booster dose of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: 12 months follow-up result of an open-label, non-randomis63
Predictors of hospitalization, death and incomplete/non-recovery from SARS-CoV-2 in an ambulatory global population63
Molecular monitoring of RNA viruses belonging to Orthohantaviridae family circulating among small mammals in two regions of the Russian Federation61
A novel smart surveillance approach to strengthen health facility-based disease surveillance in Tanzania61
Machine learning algorithm for the rapid and accurate detection of Plasmodium falciparum60
Cremian Congo Hemorrhagic Fever Outbreak Jabbi, Aug 202360
Molecular investigation of coronaviruses in Hungarian bats59
Free-living amoebae infections in humans in South Africa, 1996-202358
The battle against antimicrobial resistance is more important now than ever: Time to educate, advocate and act57
Predicting the spatio-temporal reproductive potential of Aedes aegypti57
Clinical and Molecular Epidemiology of Klebsiella pneumoniae Invasive Disease in Adults: preliminary results from a South African case-control study57
Perspectives on development and advancement of new tuberculosis vaccines56
Short and long-term immune changes in different severity groups of COVID-19 disease56
Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B)56
Dynamics of anti-SARS-CoV-2 IgG antibody responses following breakthrough infection and the predicted protective efficacy: A longitudinal community-based population study in China54
The associations between invasive group A streptococcal disease and infection with influenza, varicella, or hepatitis C viruses: A data linkage study, Victoria, Australia54
Kinetics of hepatitis B virus replication in anti-HBc positive/HBsAg-negative people with HIV switching to tenofovir sparing therapy54
Comparative effectiveness of adjuvanted versus high-dose seasonal influenza vaccines for older adults: a systematic review and meta-analysis54
Epidemiologic characteristics and clinical features of patients with monkeypox virus infection from a hospital in Peru between July and September 202252
PEDIATRIC INFLAMMATORY MULTISYSTEM SYNDROME (PIMS) AND DENGUE FEVER DURING SARS-COV-2 PANDEMIC52
Infective endocarditis and cardiac events after transcatheter vs surgical aortic valve replacement: A nationwide cohort study52
Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: a randomized, multicenter, placebo-controlled trial Healthcare Worker Exposure Response and Outcomes of Hydroxychlor52
Influence of chronic use of corticosteroids and calcineurin inhibitors on COVID-19 clinical outcomes: analysis of a nationwide registry51
NUCLEOSIDE-MODIFIED MRNA VACCINES PROTECT IFNAR -/- MICE AGAINST CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS INFECTION51
A DESCRIPTIVE, RETROSPECTIVE ANALYSIS OF COVID-19 ANTIBODY THERAPY AND ITS EFFECTS ON MORBIDITY AND MORTALITY IN PATIENTS RECEIVING B-LYMPHOCYTE DEPLETING THERAPIES51
EXPANSION OF THE NATURAL FOCUS OF THE CRIMEAN HEMORRHAGIC FEVER IN THE SOUTH OF RUSSIA51
Serological cross-reactivity between spotted fever and typhus groups of rickettsia infection in Japan49
DENGUE MICROEVOLUTIONARY PROCESSES IN WOLBACHIA-INFECTED MOSQUITO CELL LINES49
ONE-HEALTH APPROACH TO INVESTIGATE AMU AND AMR DRIVERS IN THAILAND49
0.10926198959351